SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-042866
Filing Date
2023-07-20
Accepted
2023-07-20 13:07:29
Documents
2
Period of Report
2023-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1558
2 EX-24 DOCUMENT attachment1.htm EX-24 3368
  Complete submission text file 0001209191-23-042866.txt   6295
Mailing Address C/O MYOVANT SCIENCES INC. 2000 SIERRA POINT PARKWAY, 9TH FLOOR BRISBANE CA 94005
Business Address
Lang Matthew (Reporting) CIK: 0001712069 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40502 | Film No.: 231099023

Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Issuer) CIK: 0001806952 (see all company filings)

IRS No.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations